The oxidative metabolism of estradiol conditions postmenopausal bone density and bone loss

Journal of Bone and Mineral Research

Volumn 15, Issue 12, 2000, Pages 2513-2520

  Leelawattana, Rattana ^a   Ziambaras, Konstantinos ^a   Roodman Weiss, Jane ^a   Lyss, Christine ^a   Wagner, Danielle ^b   Klug, Thomas ^b   Armamento Villareal, Reina ^a   Civitelli, Roberto ^a  

^a BARNES JEWISH HOSPITAL   (United States)

^b Immuna Care Corporation   (United States)

Author keywords

Estrogen metabolism; Postmenopausal osteoporosis; Risk factors

Indexed keywords

16ALPHA HYDROXYESTRONE; ESTRADIOL; ESTRIOL; ESTROGEN;

ADULT; ARTICLE; BONE DENSITY; CONTROLLED STUDY; ESTROGEN METABOLISM; FEMALE; HUMAN; HYDROXYLATION; MAJOR CLINICAL STUDY; OXIDATION; POSTMENOPAUSE OSTEOPOROSIS; RISK FACTOR; VERTEBRA;

BONE DENSITY; DENSITOMETRY, X-RAY; ESTRADIOL; ESTROGENS; FEMALE; FEMUR HEAD; FEMUR NECK; HUMANS; HYDROXYLATION; LUMBAR VERTEBRAE; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; OXIDATION-REDUCTION; PROSPECTIVE STUDIES;

EID: 0033714872     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.2000.15.12.2513     Document Type: Article

References (48)

1. Involutional osteoporosis
2. Long-term prevention of postmenopausal osteoporosis by estrogen. Evidence for an increased bone mass after delayed onset of estrogen treatment
3. Hip fracture and the use of estrogens in postmenopausal women
4. Estrogen replacement therapy and fractures in older women. Study of Osteoporotic Fractures Research Group
5. Estrogen status and heredity are major determinants of premenopausal bone mass
6. Effects of estrogen exposure and reproductive factors on bone mineral density and osteoporotic fractures
7. The relative contributions of age and years since menopause to postmenopausal bone loss
8. The effect of menopause on longitudinal bone loss from the spine
9. Potential value of urinary oestrogen assays in the identification of fast bone losers after the menopause
10. Total and free estrogens and androgens in postmenopausal women with hip fractures
11. Sex steroids and bone mass. A study of changes about the time of menopause
12. Body weight and/or endogenous estradiol as determinants of cortical bone mass and bone loss in healthy early postmenopausal women
13. Low levels of estradiol are associated with vertebral fractures in older men, but not women: The Rancho Bernardo Study
14. Endogenous hormones and the risk of hip and vertebral fractures among older women. Study of Osteoporotic Fractures Research Group
15. Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: A key role for bioavailable estrogen
16. Conversion of blood androgens to estrogens in normal adult men and women
17. Source of estrogen production in postmenopausal women
18. Aromatization of androstenedione to estrone by human adipose tissue in vitro. Correlation with adipose tissue mass, age, and endometrial neoplasia
19. Aromatase in bone cell: Association with osteoporosis in postmenopausal women
20. Oxidative metabolism of estradiol
21. Estrogen metabolism and excretion in Oriental and Caucasian women
22. Biological properties of 16α-hydroxyestrone: Implications in estrogen physiology and pathophysiology
23. Direction of estradiol metabolism as a control of its hormonal action-uterotropic activity of estradiol metabolites
24. Dietary and pharmacological control of estradiol metabolism in humans
25. Increased 2-hydroxylation of estradiol as a possible mechanism for the anti-estrogenic effect of cigarette smoking
26. Increased urinary catechol estrogen excretion in female smokers
27. Cimetidine inhibits catechol estrogen metabolism in women
28. Altered hydroxylation of estrogen in patients with postmenopausal osteopenia
29. Comment on altered hydroxylation of estrogen in patients with postmenopausal osteopenia
30. Differential effects of estrogen metabolites on bone and reproductive tissues of ovariectomized rats
31. Estrogen action on bone mass of postmenopausal women is dependent on body mass and initial bone density
32. Changes in levels of urinary estrogen metabolites after oral indole-3-carbinol treatment in humans
33. Monoclonal antibody-based enzyme immunoassay for simultaneous quantitation of 2- and 16 alpha-hydroxyestrone in urine
34. Updated data on proximal femur bone mineral levels of US adults
35. Influence of body habitus and race on bone mineral density of the midradius, hip, and spine in aging women
36. Influence of body weight on rates of change in bone density of the spine, hip, and radius in postmenopausal women
37. Estrogen 2-hydroxylase oxidation and menstrual function among elite oarswomen
38. Magnetic resonance imaging of overall and regional body fat, estrogen metabolism, and ovulation of athletes compared to controls
39. Differences in drug metabolism polymorphism between Orientals and Caucasians
40. Bone mineral density and risk of breast cancer in older women: The study of osteoporotic fractures. Study of Osteoporotic Fractures Research Group
41. Urinary estrogen metabolites and breast cancer: A case-control study
42. Antiestrogen action of 2-hydroxyestrone on MCF-7 human breast cancer cells
43. Opposite effects of estrogen and catecholestrogen on hormone-sensitive breast cancer cell growth and differentiation
44. Regulation of sex-hormone-binding globulin production by endogenous estrogens in vitro
45. Identification of an estrogen response element activated by metabolites of 17β-estradiol and raloxifene
46. The relationship of exercise to anovulatory cycles in female athletes: Hormonal and physical characteristics
47. Suppression of prolactin and gonadotropin secretion in postmenopausal women by 2-hydroxyestrone
48. Role of human hepatic cytochrome P450 1A2 and 3A4 in the metabolic activation of estrone